| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,711 |
8,093 |
$1.73M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,790 |
2,467 |
$807K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,135 |
1,067 |
$116K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,294 |
1,125 |
$106K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
264 |
234 |
$95K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
44 |
44 |
$87K |
| 80053 |
Comprehensive metabolic panel |
12,600 |
10,660 |
$69K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,424 |
431 |
$61K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,697 |
11,587 |
$56K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,180 |
1,871 |
$53K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
844 |
696 |
$42K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
543 |
525 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
1,128 |
994 |
$30K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
297 |
263 |
$28K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
128 |
122 |
$27K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
362 |
321 |
$27K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
893 |
845 |
$24K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
893 |
845 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
9,926 |
8,596 |
$24K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,281 |
1,181 |
$20K |
| 87481 |
|
418 |
383 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
421 |
139 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
324 |
306 |
$12K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,644 |
1,372 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
155 |
149 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
318 |
293 |
$9K |
| 87511 |
|
401 |
383 |
$9K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
387 |
369 |
$8K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
103 |
52 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
489 |
473 |
$6K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
95 |
38 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
489 |
459 |
$6K |
| 83690 |
|
1,161 |
1,045 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
176 |
68 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
693 |
645 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
196 |
185 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
203 |
190 |
$4K |
| 97602 |
|
68 |
29 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
613 |
576 |
$3K |
| 84484 |
|
693 |
456 |
$3K |
| 87070 |
|
414 |
381 |
$3K |
| 81001 |
|
1,413 |
1,274 |
$3K |
| 86696 |
|
190 |
178 |
$3K |
| 87660 |
|
175 |
159 |
$3K |
| 86747 |
|
222 |
107 |
$3K |
| 86850 |
|
284 |
256 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
41 |
36 |
$2K |
| 86787 |
|
225 |
109 |
$2K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
26 |
25 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
633 |
570 |
$2K |
| 84439 |
|
299 |
287 |
$2K |
| 86694 |
|
190 |
178 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
108 |
103 |
$2K |
| 85027 |
|
398 |
365 |
$2K |
| 86695 |
|
190 |
178 |
$2K |
| 80061 |
Lipid panel |
231 |
220 |
$2K |
| 87340 |
|
215 |
201 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
40 |
38 |
$2K |
| 81003 |
|
954 |
854 |
$2K |
| 86762 |
|
131 |
121 |
$2K |
| 86780 |
|
178 |
166 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
601 |
546 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
973 |
883 |
$1K |
| 70450 |
Computed tomography, head or brain; without contrast material |
28 |
27 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,554 |
1,048 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
491 |
451 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
611 |
525 |
$922.88 |
| 87077 |
|
101 |
96 |
$874.20 |
| 97162 |
|
14 |
14 |
$783.27 |
| 86900 |
|
276 |
248 |
$719.00 |
| 86901 |
|
273 |
248 |
$712.36 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
33 |
31 |
$712.24 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
26 |
14 |
$692.92 |
| 85610 |
|
290 |
255 |
$680.87 |
| 81025 |
|
109 |
106 |
$667.62 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
339 |
288 |
$631.59 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
42 |
40 |
$596.16 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
110 |
90 |
$507.15 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
44 |
41 |
$461.18 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
97 |
77 |
$430.50 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
155 |
112 |
$386.43 |
| 82248 |
|
80 |
62 |
$258.50 |
| 84702 |
|
13 |
12 |
$217.49 |
| 84703 |
|
27 |
26 |
$183.92 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
124 |
105 |
$169.84 |
| 87081 |
|
24 |
24 |
$144.00 |
| 85730 |
|
27 |
27 |
$139.38 |
| 82950 |
|
30 |
24 |
$117.26 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14 |
14 |
$94.24 |
| 86140 |
|
12 |
12 |
$53.46 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
46 |
40 |
$49.50 |
| 83735 |
|
13 |
12 |
$44.11 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
14 |
12 |
$26.17 |
| 11721 |
|
13 |
12 |
$0.17 |